Doctor explaining the various for options for effective and long-lasting pain reduction with hybrid replacement..

Connect to profound pain relief

Hybrid Replacement with WaveWriter Alpha™

Patients implanted with an SCS device may present with clinical issues that create the need for an upgrade. These situations are diverse and could include: lack of pain relief, lack of pain coverage, limited therapy options, system design, battery harm and/or therapy habituation. Give your patients more options for effective and long-lasting pain reduction with hybrid replacement.

 

upto 29% icon

of SCS patients have been shown to suffer from loss of efficacy and may benefit from device replacement.1

There is evidence that suggests that optimal pain relief can not be achieved just by using a single SCS treatment method or paradigm.2

Give your patients the benefits of personalised solutions

Every patient is unique, pain is dynamic, and so your approach to treating them must be personalised. Finding personalised solutions for your patients that work both today and in the future means choosing a device that offers options.

Your patients might benefit from hybrid replacement with WaveWriter Alpha when:

Limited Therapy options Icon

Limited therapy options

Developing new pain areas icon

Developing new pain areas or in need of better coverage

Therapy habituation Icon

Therapy habituation

Battery harm Icon

Battery harm

Discover the findings

Now MRI Conditional* – A first in SCS

Hybrid replacement with WaveWriter Alpha. Maintain full-body MRI access

MRI logo
  • Salvage suboptimal Abbott and Medtronic outcomes
  • Full-body MRI access with existing implanted leads
  • Available for trials and implants

 

Connect to a portfolio that makes a difference to your patients

Discover WaveWriter Alpha and connect to a portfolio that makes a difference to your patients.
Target Icon

Hit the target – and only the target.

Illumina 3D™ + MICC

Avoid overstimulation and increase responder rate by applying the therapy exactly where it is required.

Profound Relief in minutes icon

Profound pain relief in minutes.

FAST™

9/10 patients have been shown to respond to FAST at 1-year follow-up and experience profound pain relief before they leave your clinic.3 Multiple stimulation options also available for personalised therapy.

Ports Icon

Coverage made easy.

Leads and ports

Maximise coverage and effectiveness with 4 leads. Provides the option to combine SCS and PNS therapy with one device.

Learn more about the Precision S8 and M8 Adapters and how to connect them to previously implanted Abbott and Medtronic leads.

Precision™ S8 and M8 Adapters

The WaveWriter Alpha can be connected to previously implanted Abbott and Medtronic leads and lead extensions using a Precision™ S8 and M8 Adapters. Download the brochure for details and ordering information

Download the brochure
Explore the findings of an observational study and how they connect to hybrid replacement with WaveWriter Alpha.

Hybrid replacement with WaveWriter Alpha

In an observational study, SCS patients experiencing loss of efficacy reported significant  and sustained improvement in overall pain scores after converting to the WaveWriter Alpha. Explore the findings in full by clicking the button below.

Discover the study

 

1. Deer TR, et al. Neuromodulation Appropriateness Consensus Committee. The appropriate use of neurostimulation: avoidance and treatment of complications of neurostimulation therapies for the treatment of chronic pain. Neuromodulation Appropriateness Consensus Committee.
Neuromodulation. 2014 Aug;17(6):571-97; discussion 597-8

2. Metzger CS, et al. Pain relief outcomes using an SCS device capable of delivering combination therapy with advanced waveforms and field shapes. Expert Rev Med Devices. 2020 Sep;17(9):951-957.

3. Veizi et al. Spinal Cord Stimulation (SCS) with Anatomically Guided (3D) Neural Targeting Shows Superior Chronic Axial Low Back Pain Relief Compared to Traditional SCS-LUMINA Study. Pain Med. 2017 Aug 1;18(8):1534-1548. doi: 10.1093/pm/pnw286. PMID: 28108641.

4. Anitescu M, et al. Prospective, Multicenter Outcomes Utilizing an SCS-System Designed to Engage Surround Inhibition Using Fast-Acting Sub-Perception Therapy [Abstract]. Sixteenth World Congress of the International Neuromodulation Society, may 11-16th, 2024, Vancouver, BC Canada.

Caution:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructionsfor use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries..

This material is not intended for use in France.

*The WaveWriter Alpha™ SCS System provides safe access to full-body MRI scans when used with specific components and the patient is exposed to the MRI environment under the defined conditions in the ImageReady™ MRI Full Body Guidelines for WaveWriter Alpha and WaveWriter Alpha Prime Spinal Cord Stimulator System.

Person with headset Icon
Get Updates

Be among the one first to know about the latest advances in Neuromodulation.

Sign Up
icon document with magnifying glass
Join EDUCARE

Register to attend our virtual education programs and keep up with leading-edge innovations.

Explore
Icon with an open envelope.
Request a rep

Want to learn more about products and services? One of our sales representatives will be happy to contact you.

Click here